First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia.
Date
2021Author
Yenerel, Mustafa Nuri
Byrd, John C.
Hillmen, Peter
Ghia, Paolo
Kater, Arnon P.
Chanan-Khan, Asher Alban Akmal
Furman, Richard R.
O'Brien, Susan M.
Illes, Arpad
Kay, Neil E.
Marco, Jose Antonio Garcia
Mato, Anthony R.
Francis, John
Lepretre, Seymour Stephane
Stilgenbauer, Stephan
Robak, Tadeusz
Patel, Priti
Higgins, Kara
Sohoni, Sophia
Jurczak, Wojciech
Metadata
Show full item recordCollections
- Makale [92796]